FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS

Rahman, P, Ritchlin, CT, Helliwell, P et al. (13 more authors) (2020) FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS. In: EULAR 2020, 03-06 Jun 2020, Online.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
  • Rahman, P
  • Ritchlin, CT
  • Helliwell, P
  • Boehncke, WH
  • Mease, PJ
  • Gottlieb, AB
  • Kafka, S
  • Kollmeier, A
  • Hsia, EC
  • Xu, XL
  • Shawi, M
  • Sheng, S
  • Agarwal, P
  • Zhou, B
  • Ramachandran, P
  • Mcinnes, I
Dates:
  • Published: June 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 01 Oct 2020 12:06
Last Modified: 01 Oct 2020 12:06
Status: Published
Identification Number: 10.1136/annrheumdis-2020-eular.387
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)